Reconstitution of trabecular meshwork GAGs: influence of hyaluronic acid and chondroitin sulfate on flow rates.
OBJECTIVE
This study was undertaken to determine whether the concentration of hyaluronic acid (HA) and of chondroitin sulfate (CS) occurring in the normal and the primary open-angle glaucoma (POAG) trabecular meshwork (TM) influences flow rates in vitro as a function of pressure.


METHODS
We tested 100, 500, and 4000 kDa molecular weight HA, CS, reconstituted normal and POAG TM HA-CS and juxtacanalicular connective tissue (JCT) HA-CS in a micro test chamber to determine initial and steady-state flow rates. The resistance and permeability (Ko) were calculated; Linear Newtonian mechanics were used to determine the possible contributions of the hydrophobic interactions of HA.


RESULTS
Initial flow rates increased in the pressure range of 5 to 20 mm Hg for the three HA preparations and the flow rates declined in the pressure range of 20 to 40 mm Hg. Flow rates of reconstituted normal TM and JCT were optimum at 10 mm Hg and then declined with increasing pressure. Flow rates of reconstituted POAG TM and JCT were optimum only at 5 mm Hg and then declined. The steady-state rate of POAG JCT HA-CS at 10 mm Hg was slow: the transition time (ie, the time required to start an increase in flow rate) was 29 hours and the lag time (ie, the time required to obtain steady-state flow rate) was 17 hours. The maximum flow rate in POAG JCT HA-CS decreased by 37.2% from the normal JCT HA-CS. The calculated resistance of reconstituted POAG JCT HA-CS was approximately 18% of the total resistance of the human JCT compared with 10% in the normal JCT.


CONCLUSIONS
Hyaluronic acid and CS contribute to flow resistance and influence flow rate in vitro. The influence of HA is particularly sensitive to an increase in the pressure gradient, which may be caused by unfolding of the hydrophobic interactions of HA polymers that further entangles the HA polymer. The POAG JCT HA-CS concentrations represent a significant factor in outflow resistance in POAG, particularly at higher pressures.
Knepper
Paul A
PA
Laboratory for Oculo-Cerebrospinal Investigation, Division of Neurosurgery, Children's Memorial Medical Center and Department of Ophthalmology, Northwestern University Medical School, Chicago, IL, USA. pknepper@northwestern.edu
Fadel
James R
JR
Miller
Adam M
AM
Goossens
William
W
Choi
John
J
Nolan
Michael J
MJ
Whitmer
Susan
S
D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism*; D002809:Chondroitin Sulfates / Q000494:pharmacology*; D003238:Connective Tissue / Q000378:metabolism; D004338:Drug Combinations; D004591:Electrophoresis, Polyacrylamide Gel; D005902:Glaucoma, Open-Angle / Q000378:metabolism*; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D008962:Models, Theoretical; D008970:Molecular Weight; D010539:Permeability / Q000187:drug effects; D011312:Pressure; D014129:Trabecular Meshwork / Q000378:metabolism*
D004338:Drug Combinations; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates